期刊文献+

抗U1RNP抗体阳性患者血清抗人类肺动脉内皮细胞自身抗体的发现及其意义 被引量:2

Identification of autoantibodies against human pulmonary artery endothelial cells in anti-U1RNP antibody-positive patients with systemic autoimmune diseases and its significance in vascular damage
原文传递
导出
摘要 目的检测抗U1RNP抗体阳性的自身免疫性疾病患者血清中抗人类肺动脉内皮细胞(HPAEC)自身抗体,并探讨其对肺动脉血管内皮损害的作用机制。方法通过RNA免疫沉降法筛选抗U1RNP抗体阳性血清,免疫印记分析检测血清中抗HPAEC自身抗体。通过流式细胞分析术,确定抗体靶抗原是否位于细胞的表面。用酶联免疫吸附试验(ELISA)测定含有该自身抗体IgG的HPAEC培养上清中活化T细胞调节的正常T细胞表达和分泌的因子(RANTES)的浓度。结果抗U1RNP抗体阳性血清中新发现一种同HPAEC表面相对分子质量31000抗原(HPA31抗原)反应的自身抗体,把含抗HPA31抗体的血清IgG分离纯化后加入HPAEC培养上清中,RANTES的量明显增加。结论自身免疫性疾病患者血清中存在与抗U1RNP抗体有一定相关的抗HPA31抗体,该抗体同细胞表面的靶抗原结合,可以活化HPAEC,促进RANTES产生及分泌,导致肺动脉血管内皮细胞的炎症损害。 Objective To identify specific autoantibodies against human pulmonary artery endothelial cells (HPAEC) in sera of patients with systemic autoimmune diseases and investigate its possible role in vascular damage. Methods Sera with anti-U1RNP antibodies (Abs) were selected through RNA immunoprecipitation assay, and autoantibodies against autoantigens of HPAEC were detected by immunobloto Flow cytomety analysis was used to reveal whether or not antigenic determinants of autoantibodies against HPAEC appeared on the surface of the cells. Chemokine secreted upon activation of normal T-cells and RANTES concentration in the culture supernatant after adding of IgG purified from anti-HPAEC Ab-positive sera was detected by ELISA. Results Autoantibodies that recognized specific autoantigens 31 000 (HPA31) for HPAEC were newly identified. Antigenic determinants of HPA31 appeared on the surface of HPAEC. RANTES concentration in culture supernatant after adding of IgG purified from anti-HPA31 Ab-positive sera was significantly higher than anti-HPA31-negative sera. Conclusion Autoantibodies against HPAEC (anti-HPA31 Ab) exist in association with anti-U1RNP Ab-positve sera of patients with systemic autoimmune diseases. Anti-HPA31 Ab may activate HPAEC and stimulate RANTES. It may be involved in the process of inflammatory vascular damage.
出处 《中华风湿病学杂志》 CAS CSCD 2007年第3期149-153,共5页 Chinese Journal of Rheumatology
关键词 内皮细胞 自身抗体 肺动脉 Endothelial cells Autoantibodies Pulmonary artery
  • 相关文献

参考文献17

  • 1Wiener-Kronish JP, Solinger AM, Warnock ML, et al. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis, 1981, 124: 499-503.
  • 2Sullivan WD, Hurst DJ, Harmon CE, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine, 1984, 63: 92-107.
  • 3Hosoda Y, Suzuki Y, Takano M, et al. Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study. J Rheumatol, 1987, 14: 826-830.
  • 4Kasukawa R, Nishinaki T, Takagi T, et al. Palmonary hypertension in connective tissue disease: clinical analysis of sixty pateints in multi-institutional study. Clin Rheumatol, 1990, 9:56-62,
  • 5Bodolay E, Csipo I, Gal I, et al. Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms. Clin Exp Rheumatol, 2004, 22: 409-415.
  • 6Horvathova M, Jahnova E, Nyulassy S. Detection of antiendothelial cell antibodies in patients with connective tissue diseases by flow cytometry and their relation to endothelial cell activation.Physiol Res, 2002, 51: 613-617.
  • 7Belizna C, Tervaert JW. Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies. Semin Arthritis Rheum,1997, 27: 98-109.
  • 8Yoshio T, Masuyama J, Sumiya M, et al. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol, 1994, 21: 2058-2063.
  • 9Fujii T, Mimori T, Hama N, et al. Characterization of autoantibodies that recognize U4/U6 small ribonueleoprotein particles in serum from a patient with primary Sjogren's syndrome. J Biol Chem, 1992, 267: 16412-16416.
  • 10Okawa-Takatsuji M, Aotsuka S, Fujinami M, et al. Up-regulation of intercellular adhesion molecule-1 (ICAM-I) and class Ⅱ MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein. Clin Exp Immunol, 1999, 116: 174-180.

二级参考文献19

  • 1Simonneau G,Galie N,Rubin LJ,et al.Clinical classification of pulmonary hypertension.J Am Coll Cardiol,2004,43 (Suppl):5-12.
  • 2Farber HW,Loscalzo J.Mechanisms of disease:pulmonary arterial hypertension.New Engl J Med,2004,351:1655-1665.
  • 3Tan EM,Cohen AS,Fries JF,et al.The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE).Arthritis Rheum,1982,25:1271-1277.
  • 4Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee.Preliminary criteria for the classification of sclerosis (scleroderma).Arthritis Rheum,1980,23:581-590.
  • 5Vitali C,Bombardieri S,Moutsopoulos HM,et al.Preliminary criteria for the classification of Sjogren's syndrome.Arthritis Rheum,1993,36:340-347.
  • 6Bohan A,Peter JB.Polymyositis and dermatomyositis (first of two parts).New Engl J Med,1975,292:344-347.
  • 7Wilson WA,Gharavi AE,Koike T,et al.International consensus statement on preliminary classfication criteria for definite antiphospholipid antibody syndrome.Report of an international workshop.Arthritis Rheum,1999,42:1309-1311.
  • 8Sharp GC,Irvin WS,Tan EM.Mixed connective tissue disease:an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).Am J Med,1972,52:148-149.
  • 9Silver RM.Scleroderma-clinical problems:the lungs.Rheum Dis Clin North Am,1996,22:25-40.
  • 10Bolster MB,Silver RM.Lung disease in systemic sclerosis (scleroderma).Baillieres Clin Rheumatol,1993,7:79-97.

共引文献22

同被引文献37

  • 1杨萍,赵贺红(综述),冯萍(审校).艾滋病相关性肺动脉高压诊治近况[J].医学信息(医学与计算机应用),2014,0(11):539-540. 被引量:1
  • 2陈彦凡,陈少贤,范小芳,王良兴.地塞米松对大鼠慢性肺动脉高压血管内皮生长因子表达的影响[J].中华老年医学杂志,2004,23(10):731-732. 被引量:3
  • 3曾学军,朱卫国,邓学新,唐福林,董怡.系统性血管炎抗内皮细胞抗体的检测及其与病情活动的相关性[J].中华医学杂志,2004,84(19):1629-1632. 被引量:7
  • 4杨宁,赵成,刘布骏,孙凌云.结缔组织病并发肺动脉高压110例临床分析[J].中华风湿病学杂志,2007,11(9):552-555. 被引量:20
  • 5PERROS F, DORFMULLER P, MONTANI D, et al. Pulmo- nary lymphoid neogenesis in idiopathic pulmonary arterial hy- pertension[J]. American Journal of Respiratory and Critical Care Medicine, 2012,185(3) :311 321.
  • 6PRICE L C, WORTS J, PERROS F, et al. Inflammation in pulmonary arterial hypertension[J]. CHEST, 2012,141 (1) : 210-221.
  • 7HUMBERT M, MONTI G, BRENOT F, et al. Increased in- terleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension[J]. American Journal of Re- spiratory and Critical Care Medicine, 1995,151(5) :1628-1631.
  • 8BALABANIAN K, FOUSSAT A, DORFMULLER P, et al. CX(3) C chemokine Iractalkine in pulmonary arterial hyperten sion[J]. American Journal of Respiratory and Critical Care Medicine, 2002,165(10) :1419-1425.
  • 9ULRICH S, NICOLLS M R, TARASEVICIENE L, et al. In- creased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hyperten- sion/-J. Respiration; International Review of Thoracic Disea- ses, 2008,75(3) :272-280.
  • 10HECKER M, ZASLONA Z, KWAPISZEWSKA G, et al. Dysregulation of the IL-13 receptor system: a novel patho mechanism in pulmonary arterial hypertension[J]. American Journal of Respiratory and Critical Care Medicine, 2010, 182 (6) :805-818.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部